Dr Leonard Wartofsky from Georgetown University Hospital, United States, shares his thoughts on the 3 most important recent advances in the management of thyroid diseases.
Dr Bess Dawson-Hughes from Tufts University School of Medicine, United States, offers her view on the 3 most important recent advances in the management of osteoporosis.
Dr Hertzel Gerstein from McMaster University shares his views on the 3 most important recent advances in treating diabetes.
Dr Dror Dicker from Tel Aviv University shares his views on the 3 most important recent advances in treating obesity.
Does levothyroxine therapy reduce the risk of pregnancy loss in thyroid peroxidase antibody (TPOAb)-positive euthyroid women who are newly pregnant?
What is the appropriate treatment in patients with severe hypothyroidism and myxedema coma? What thyroid hormones should be administered (T4 and T3 administered together or separately)? What dosing should be used?
What are the key diagnostic criteria for myxedema coma? What signs and symptoms are the most alarming?
What is the most important change in the management of type 2 diabetes according to the 2018 consensus report by the American Diabetes Association (ADA) and the European Association of the Study of Diabetes (EASD)?
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors increase renal glucose excretion. Can they be used in older patients with diabetes who often have bacterial colonization but no urinary tract infections?
English
Polski
Español
українська